4/A

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: December 22, 2010
Period of Report: November 15, 2010
Accession Number: 0001437749-10-004515

View Document ↗ View on SEC.gov ↗